Age (y), (mean ± SD)
|
66.6 ± 8.2
|
Male, n (%)
|
214 (91.8)
|
Smoking, n (%)
|
166 (71.2)
|
Coexisting disease, n (%)
| |
COPD
|
21 (9.0)
|
Hypertension
|
58 (24.9)
|
Diabetes
|
11 (4.7)
|
Dyspnea index, n (%)
|
13 (2.5)
|
0
|
42 (18.0)
|
1
|
9 (3.9)
|
2
|
27 (11.6)
|
3
|
30 (12.9)
|
4
|
125 (53.6)
|
Location of the lesion, n (%)
| |
Trachea
|
34 (14.6)
|
Left main bronchus
|
75 (32.2)
|
Right main bronchus
|
78 (33.5)
|
Right intermediate bronchus
|
46 (19.7)
|
Initial degree of MCAS, (mean ± SD, %)
|
76.9 ± 23.9
|
Post-intervention residual stenosis, (mean ± SD, %)
|
28.4 ± 17.3
|
Histological types, n (%)
| |
Lung adenocarcinoma
|
5 (2.1)
|
Lung squamous cell carcinoma
|
186 (79.8)
|
SCLC
|
17 (7.3)
|
Other*
|
25 (10.7)
|
Stent implantation, n (%)
|
56 (24.0)
|
Other treatments after intervention,** n (%)
| |
0
|
50 (21.5)
|
1
|
81 (34.8)
|
≥ 2
|
102 (43.8)
|
Severe restenosis, n (%)
|
92 (39.5)
|